Global Pharmacy Repackaging Systems Market Size, Share, Trends, Industry Growth by Product (Blister Card/Compliance, Liquid Medication, Bottle Filling/Pill Counting, Pouch Packaging, Others), by Dosage Type (Unit Dose Packaging, Multiple Unit Packaging), End-User, and Forecast to 2027
Report ID: RC114631 | Report Format: PDF + Excel | Starting Price: 3600/- USD | Last Updated: June 23rd, 2023The global pharmacy repackaging systems market size is accounted to register a significant CAGR of around 7.5% during the forecast period and is expected to reach over USD 2 billion by 2027. The rising number of medication errors and stringent regulations are some major factors to drive the market growth. Furthermore, the focus on improving patient safety, the rising adoption of automated systems, and the growing importance are expected to fuel the market growth over the forecast period. Moreover, the increasing number of outpatient visits and focus on improving drug inventory management are anticipated to propel the market growth.
Market Drivers:
Increasing demand for medication adherence: Medication non-adherence is a significant concern in healthcare, leading to poor patient outcomes and increased healthcare costs. Pharmacy repackaging systems help improve medication adherence by providing customized packaging solutions, such as unit-dose blister packs or multi-dose strip packaging, which make it easier for patients to follow their prescribed medication regimens.
Rising emphasis on patient safety: Patient safety is a critical factor in healthcare. Pharmacy repackaging systems play a crucial role in enhancing patient safety by reducing medication errors, such as incorrect dosages or medication mix-ups. These systems incorporate barcode scanning, automated labeling, and verification processes to ensure accurate and safe dispensing of medications.
Growing pharmaceutical industry and drug distribution: The pharmaceutical industry is experiencing significant growth, with an increasing number of medications being developed and distributed worldwide. Pharmacy repackaging systems are necessary to handle the packaging and labeling of medications in different formats and volumes, supporting the efficient distribution of drugs to pharmacies and healthcare facilities.
Expansion of long-term care facilities and home healthcare: Long-term care facilities, such as nursing homes and assisted living centers, and home healthcare services are witnessing growth due to aging populations and the preference for home-based care. Pharmacy repackaging systems are essential in these settings to ensure the safe and organized dispensing of medications to residents or patients.
Regulatory compliance and medication traceability: Stringent regulations govern the pharmaceutical industry to ensure patient safety and product quality. Pharmacy repackaging systems help pharmacies and healthcare facilities comply with regulations related to medication labeling, traceability, and tamper-evident packaging. These systems enable accurate tracking and documentation of medication dispensing activities.
Technological advancements in packaging automation: Advancements in packaging automation technology have improved the efficiency and accuracy of pharmacy repackaging systems. Automated systems can handle high volumes of medications, perform barcode scanning and verification, and integrate with electronic health records (EHR) systems, optimizing workflow and reducing manual errors.
Cost savings and operational efficiency: Pharmacy repackaging systems contribute to cost savings and operational efficiency for pharmacies and healthcare facilities. These systems streamline medication dispensing processes, reduce labor requirements, minimize medication waste, and optimize inventory management, resulting in improved operational efficiency and financial benefits.
Increasing focus on personalized medicine: Personalized medicine, which involves tailoring medication regimens based on individual patient characteristics, is gaining prominence. Pharmacy repackaging systems can facilitate the customization of medication packaging and dosing to meet the unique needs of individual patients, supporting the advancement of personalized medicine.
Shift towards outpatient care and retail pharmacies: The shift towards outpatient care and the expansion of retail pharmacy services have increased the demand for efficient medication dispensing systems. Pharmacy repackaging systems enable retail pharmacies to handle prescription filling and dispensing efficiently, improving patient convenience and satisfaction.
Market Snapshot:
Benchmark Year | 2022 | ||
Market Size | > USD 2 Billion by 2027 | ||
Market Growth (CAGR) | ~ 7.5% (2023-2030) | ||
Largest Market Share | North America | ||
Analysis Period | 2020-2030 | ||
Market Players | Omnicell, Inc., Becton Dickinson & Company, Kirby Lester, Swisslog Holding Ltd., and Yuyama Co., Ltd. |
Market Insights:
The global pharmacy repackaging systems market is bifurcated into the product, dosage type, end-user, and geography. On the basis of product, the market is further segmented into blister card/compliance packaging systems, liquid medication packaging systems, and others. The blister card/compliance packaging systems segment dominated the global market and anticipated to hold the largest revenue share of around one-third percent of the market by the end of the analysis period. The segment is also accounted to grow at the highest growth rate over the forecast period. The liquid medication packaging systems segment is also estimated to hold a significant market share around one-fourth share of the market.
On the basis of end-user, the global pharmacy repackaging systems market is segmented into retail, inpatient pharmacy, long-term care (LTC) pharmacies, and others. The retail segment is accounted to grow at a significant growth rate over the forecast period. The rapid growth in large chain pharmacy stores and the increasing demand for automated systems in pharmacies are some major factors to drive the segment growth. Furthermore, the rising adoption of automated systems in pharmacies in developed economies is further anticipated to fuel the segment growth over the forecast period.
To know more about the report, request sample papers
The pharmacy repackaging systems comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2021 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.
The pharmacy repackaging systems market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.
Historical & Forecast Period
- 2018-19 – Historical Year
- 2020 – Base Year
- 2021-2027 – Forecast Period
Market Segmentation:
By Product:
- Blister Card/Compliance Packaging Systems
- Liquid Medication Packaging Systems
- Bottle Filling/Pill Counting Automation Systems
- Pouch Packaging Automation Systems
- Others
By Dosage Type:
- Unit Dose Packaging
- Multiple Unit Packaging
By End-User:
- Retail/Community Pharmacy
- Inpatient Pharmacy
- Long-term care (LTC) pharmacies
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Geographic Coverage
Geographically, North America dominated the global pharmacy repackaging systems market in 2020 and estimated to hold the largest revenue share of over one-third percent of the market. The United States holds the largest market share in North America due to the increasing awareness regarding automated systems in pharmacies and stringent healthcare regulations. Furthermore, technological advancement and the rising demand for unit-dose packaging are expected to fuel the market growth in the region.
Competitive Assessment
Some of the major market players operating in the global pharmacy repackaging systems market are Omnicell, Inc., Becton Dickinson & Company, Kirby Lester, Swisslog Holding Ltd., and Yuyama Co., Ltd. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.
Key Companies:
- Omnicell, Inc.
- Becton Dickinson & Company
- Kirby Lester
- Swisslog Holding Ltd.
- Yuyama Co., Ltd.
- TCGRx
- ARxIUM
- Takazono Corporation
- Parata Systems
- Pearson Medical Technologies
Key Questions Answered by Pharmacy Repackaging Systems Market Report
- Global pharmacy repackaging systems market forecasts from 2021-2027
- Regional pharmacy repackaging systems market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
- Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
- Pharmacy repackaging systems submarket forecasts from 2021-2027 covering the market by product, by dosage type, by end-user, and geography
- Various industry models such as SWOT analysis, Value Chain Analysis pertaining to pharmacy repackaging systems market
- Analysis of the key factors driving and restraining the growth of the global, regional, and country-level pharmacy repackaging systems markets from 2021-2027
- Competitive Landscape and market positioning of top 10 players operating in the pharmacy repackaging systems market
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions
2. Executive Summary
2.1. Global Polysulfides Market Portraiture
2.2. Global Polysulfides Market, by Product, 2020 (USD Mn)
2.3. Global Polysulfides Market, by Dosage Type, 2020 (USD Mn)
2.4. Global Polysulfides Market, by End-User, 2020 (USD Mn)
2.5. Global Polysulfides Market, by Geography, 2020 (USD Mn)
3. Global Polysulfides Market Analysis
3.1. Polysulfides Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. Porter’s Five Force Analysis
3.6.1. Bargaining Power of Suppliers
3.6.2. Bargaining Power of Buyers
3.6.3. Threat of New Entrants
3.6.4. Threat of Substitutes
3.6.5. Degree of Competition
3.7. COVID-19 Impact Analysis
4. Global Polysulfides Market By Product, 2018 – 2027 (USD Mn)
4.1. Overview
4.2. Blister Card/Compliance Packaging Systems
4.3. Liquid Medication Packaging Systems
4.4. Bottle Filling/Pill Counting Automation Systems
4.5. Pouch Packaging Automation Systems
4.6. Others
5. Global Polysulfides Market By Dosage Type, 2018 – 2027 (USD Mn)
5.1. Overview
5.2. Unit Dose Packaging
5.3. Multiple Unit Packaging
6. Global Polysulfides Market By End-User, 2018 – 2027 (USD Mn)
6.1. Overview
6.2. Retail/Community Pharmacy
6.3. Inpatient Pharmacy
6.4. Long-term care (LTC) pharmacies
6.5. Others
7. North America Polysulfides Market Analysis and Forecast, 2018 – 2027 (USD Mn)
7.1.1. Overview
7.1.2. North America Polysulfides Market by Product (2018-2027 USD Mn)
7.1.3. North America Polysulfides Market by Dosage Type (2018-2027 USD Mn)
7.1.4. North America Polysulfides Market by End-User (2018-2027 USD Mn)
7.1.5. North America Polysulfides Market by Country (2018-2027 USD Mn)
7.1.5.1. U.S.
7.1.5.1.1. U.S. Polysulfides Market by Product (2018-2027 USD Mn)
7.1.5.1.2. U.S. Polysulfides Market by Dosage Type (2018-2027 USD Mn)
7.1.5.1.3. U.S. Polysulfides Market by End-User (2018-2027 USD Mn)
7.1.5.2. Canada
7.1.5.2.1. Canada Polysulfides Market by Product (2018-2027 USD Mn)
7.1.5.2.2. Canada Polysulfides Market by Dosage Type (2018-2027 USD Mn)
7.1.5.2.3. Canada Polysulfides Market by End-User (2018-2027 USD Mn)
8. Europe Polysulfides Market Analysis and Forecast, 2018 – 2027 (USD Mn)
8.1.1. Overview
8.1.2. Europe Polysulfides Market by Product (2018-2027 USD Mn)
8.1.3. Europe Polysulfides Market by Dosage Type (2018-2027 USD Mn)
8.1.4. Europe Polysulfides Market by End-User (2018-2027 USD Mn)
8.1.5. Europe Polysulfides Market by Country (2018-2027 USD Mn)
8.1.5.1. Germany
8.1.5.1.1. Germany Polysulfides Market by Product (2018-2027 USD Mn)
8.1.5.1.2. Germany Polysulfides Market by Dosage Type (2018-2027 USD Mn)
8.1.5.1.3. Germany Polysulfides Market by End-User (2018-2027 USD Mn)
8.1.5.2. U.K.
8.1.5.2.1. U.K. Polysulfides Market by Product (2018-2027 USD Mn)
8.1.5.2.2. U.K. Polysulfides Market by Dosage Type (2018-2027 USD Mn)
8.1.5.2.3. U.K. Polysulfides Market by End-User (2018-2027 USD Mn)
8.1.5.3. France
8.1.5.3.1. France Polysulfides Market by Product (2018-2027 USD Mn)
8.1.5.3.2. France Polysulfides Market by Dosage Type (2018-2027 USD Mn)
8.1.5.3.3. France Polysulfides Market by End-User (2018-2027 USD Mn)
8.1.5.4. Italy
8.1.5.4.1. Italy Polysulfides Market by Product (2018-2027 USD Mn)
8.1.5.4.2. Italy Polysulfides Market by Dosage Type (2018-2027 USD Mn)
8.1.5.4.3. Italy Polysulfides Market by End-User (2018-2027 USD Mn)
8.1.5.5. Rest of Europe
8.1.5.5.1. Rest of Europe Polysulfides Market by Product (2018-2027 USD Mn)
8.1.5.5.2. Rest of Europe Polysulfides Market by Dosage Type (2018-2027 USD Mn)
8.1.5.5.3. Rest of Europe Polysulfides Market by End-User (2018-2027 USD Mn)
9. Asia Pacific Polysulfides Market Analysis and Forecast, 2018 – 2027 (USD Mn)
9.1.1. Overview
9.1.2. Asia Pacific Polysulfides Market by Product (2018-2027 USD Mn)
9.1.3. Asia Pacific Polysulfides Market by Dosage Type (2018-2027 USD Mn)
9.1.4. Asia Pacific Polysulfides Market by End-User (2018-2027 USD Mn)
9.1.5. Asia Pacific Polysulfides Market by Country (2018-2027 USD Mn)
9.1.5.1. China
9.1.5.1.1. China Polysulfides Market by Product (2018-2027 USD Mn)
9.1.5.1.2. China Polysulfides Market by Dosage Type (2018-2027 USD Mn)
9.1.5.1.3. China Polysulfides Market by End-User (2018-2027 USD Mn)
9.1.5.2. Japan
9.1.5.2.1. Japan Polysulfides Market by Product (2018-2027 USD Mn)
9.1.5.2.2. Japan Polysulfides Market by Dosage Type (2018-2027 USD Mn)
9.1.5.2.3. Japan Polysulfides Market by End-User (2018-2027 USD Mn)
9.1.5.3. Rest of Asia Pacific
9.1.5.3.1. Rest of Asia Pacific Polysulfides Market by Product (2018-2027 USD Mn)
9.1.5.3.2. Rest of Asia Pacific Polysulfides Market by Dosage Type (2018-2027 USD Mn)
9.1.5.3.3. Rest of Asia Pacific Polysulfides Market by End-User (2018-2027 USD Mn)
10. Latin America (LATAM) Polysulfides Market Analysis and Forecast, 2018 – 2027 (USD Mn)
10.1.1. Overview
10.1.2. Latin America Polysulfides Market by Product (2018-2027 USD Mn)
10.1.3. Latin America Polysulfides Market by Dosage Type (2018-2027 USD Mn)
10.1.4. Latin America Polysulfides Market by End-User (2018-2027 USD Mn)
10.1.5. Latin America Polysulfides Market by Country (2018-2027 USD Mn)
10.1.5.1. Brazil
10.1.5.1.1. Brazil Polysulfides Market by Product (2018-2027 USD Mn)
10.1.5.1.2. Brazil Polysulfides Market by Dosage Type (2018-2027 USD Mn)
10.1.5.1.3. Brazil Polysulfides Market by End-User (2018-2027 USD Mn)
10.1.5.2. Mexico
10.1.5.2.1. Mexico Polysulfides Market by Product (2018-2027 USD Mn)
10.1.5.2.2. Mexico Polysulfides Market by Dosage Type (2018-2027 USD Mn)
10.1.5.2.3. Mexico Polysulfides Market by End-User (2018-2027 USD Mn)
10.1.5.3. Rest of Latin America
10.1.5.3.1. Rest of Latin America Polysulfides Market by Product (2018-2027 USD Mn)
10.1.5.3.2. Rest of Latin America Polysulfides Market by Dosage Type (2018-2027 USD Mn)
10.1.5.3.3. Rest of Latin America Polysulfides Market by End-User (2018-2027 USD Mn)
11. Middle East and Africa Polysulfides Market Analysis and Forecast, 2018 – 2027 (USD Mn)
11.1.1. Overview
11.1.2. MEA Polysulfides Market by Product (2018-2027 USD Mn)
11.1.3. MEA Polysulfides Market by Dosage Type (2018-2027 USD Mn)
11.1.4. MEA Polysulfides Market by End-User (2018-2027 USD Mn)
11.1.5. Middle East and Africa Polysulfides Market, by Country (2018-2027 USD Mn)
11.1.5.1. GCC
11.1.5.1.1. GCC Polysulfides Market by Product (2018-2027 USD Mn)
11.1.5.1.2. GCC Polysulfides Market by Dosage Type (2018-2027 USD Mn)
11.1.5.1.3. GCC Polysulfides Market by End-User (2018-2027 USD Mn)
11.1.5.2. South Africa
11.1.5.2.1. South Africa Polysulfides Market by Product (2018-2027 USD Mn)
11.1.5.2.2. South Africa Polysulfides Market by Dosage Type (2018-2027 USD Mn)
11.1.5.2.3. South Africa Polysulfides Market by End-User (2018-2027 USD Mn)
11.1.5.3. Rest of MEA
11.1.5.3.1. Rest of MEA Polysulfides Market by Product (2018-2027 USD Mn)
11.1.5.3.2. Rest of MEA Polysulfides Market by Dosage Type (2018-2027 USD Mn)
11.1.5.3.3. Rest of MEA Polysulfides Market by End-User (2018-2027 USD Mn)
12. Company Profiles
12.1. Omnicell, Inc.
12.1.1. Business Description
12.1.2. Financial Health and Budget Allocation
12.1.3. Product Positions/Portfolio
12.1.4. Recent Development
12.1.5. SWOT Analysis
12.2. Becton Dickinson & Company
12.2.1. Business Description
12.2.2. Financial Health and Budget Allocation
12.2.3. Product Positions/Portfolio
12.2.4. Recent Development
12.2.5. SWOT Analysis
12.3. Kirby Lester
12.3.1. Business Description
12.3.2. Financial Health and Budget Allocation
12.3.3. Product Positions/Portfolio
12.3.4. Recent Development
12.3.5. SWOT Analysis
12.4. Swisslog Holding Ltd.
12.4.1. Business Description
12.4.2. Financial Health and Budget Allocation
12.4.3. Product Positions/Portfolio
12.4.4. Recent Development
12.4.5. SWOT Analysis
12.5. Yuyama Co., Ltd.
12.5.1. Business Description
12.5.2. Financial Health and Budget Allocation
12.5.3. Product Positions/Portfolio
12.5.4. Recent Development
12.5.5. SWOT Analysis
12.6. TCGRx
12.6.1. Business Description
12.6.2. Financial Health and Budget Allocation
12.6.3. Product Positions/Portfolio
12.6.4. Recent Development
12.6.5. SWOT Analysis
12.7. ARxIUM
12.7.1. Business Description
12.7.2. Financial Health and Budget Allocation
12.7.3. Product Positions/Portfolio
12.7.4. Recent Development
12.7.5. SWOT Analysis
12.8. Takazono Corporation
12.8.1. Business Description
12.8.2. Financial Health and Budget Allocation
12.8.3. Product Positions/Portfolio
12.8.4. Recent Development
12.8.5. SWOT Analysis
12.9. Parata Systems
12.9.1. Business Description
12.9.2. Financial Health and Budget Allocation
12.9.3. Product Positions/Portfolio
12.9.4. Recent Development
12.9.5. SWOT Analysis
12.10. Pearson Medical Technologies
12.10.1. Business Description
12.10.2. Financial Health and Budget Allocation
12.10.3. Product Positions/Portfolio
12.10.4. Recent Development
12.10.5. SWOT Analysis
$ 6995/- Corporate License

Email: sales@researchcorridor.com
- Markets in over 100+ countries analyzed granularly
- 35% of our total client are returning clients
- 1000+ customers globally
- 100+ paid data sources mined to bring cutting-edge insights
- 24x5 availability - we are always there when you need us
- "Free of Cost Report Customization" is available
- Request a regional report at Best Price

- Vibration Monitoring Market Report
- Extracorporeal CO2 Removal Devices Market Report
- Friction Stir Welding Equipment Market Report
- Aseptic Filling Machines Market Report
- Range Cookers Market Report
- Industrial Food Blanchers Market Report
- Aseptic Packaging Equipment Market Report
- Indoor Climbing Walls Market Report
- Fire Extinguisher Inspection Services Market Report
- Arbovirus Testing Market Report
- Fire Extinguisher Refilling Services Market Report
- DNA Barcoding Services Market Report